New connectivity for point-of-care HbA1c analysers

New connectivity for point-of-care HbA1c analysers

A new connectivity package for EKF’s Quo-Test and Quo-Lab HbA1c analysers enables secure bidirectional communication between these POC analysers and a multitude of central data management systems. Using...

Supplied by EKF Diagnostics


A new connectivity package for EKF’s Quo-Test and Quo-Lab HbA1c analysers enables secure bidirectional communication between these POC analysers and a multitude of central data management systems. Using the industry recognized POCT1-A2 communication protocol, EKF’s connectivity solution unlocks a host of new features aimed at improving security and quality control (QC) for diabetic HbA1c testing. The new connectivity package includes a proprietary connector interface box, cables and a software upgrade. This enables EKF’s HbA1c analysers to automatically transmit patient data to the majority of Lab Information Management Systems (LIMS) or Hospital Information Systems (HIS). Traceability and results recall speed are improved by use of patient ID and increased demographic data (such as family name and date of birth). These can now be recorded through either selecting from a pre-approved list or via the barcode scanner and keyboard. Also ensuring the integrity of results generated at the POC, security and QC are enhanced on Quo-Lab and Quo-Test through user ID and QC lockout functions which are included in the connectivity package. By restricting access to trained users only, the lockout functions minimize the chances of user error and adhere to security protocols in many institutions. Furthermore, unauthorized users will be prevented from accessing patient information. Multiple user-defined QC lockout options are also available to POCT coordinators in order to enforce regular testing of QC materials and ensure compliance. HbA1c, or glycated hemoglobin, is well recognized as a reliable measure for glycemic control and managing patients with diabetes. As HbA1c levels reflect average circulating glucose concentration over a two to three month period, this means that it can offer greater clinical information than a single glucose measurement. Quo-Lab and Quo-Test analysers deliver lab-quality results for HbA1c from 4μL of blood within 4 minutes, enabling the consulting clinician to give immediate feedback to a patient. In addition to ensuring the reliability of results, the new connectivity package also allows the clinician to add commentary to any test result, further enhancing the monitoring and management of diabetes in a point-of-care setting.


Contact form

Get in touch directly with the above supplier

Your email address will not be communicated to any third party other than the above supplier for the purpose of fulfilling this enquiry. For more information: read our privacy policy.